News
ICViewExpert PerspectivesMedical World NewsVideosWebinars
Conference
Infection Control TodaySupplements And Featured Publications
CME/CEJob BoardPartnersSponsoredWhitepapers
Print SubscriptioneNewsletter
Educator of the Year Nomination FormEducator of the Year Official RulesEducator of the Year
Advanced Technology
Bug of the Month
COVID-19
Environmental Services
HAIs
Hand Hygiene
Long-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Prevention
Sterile Processing
Surface Disinfection
Vascular Access
Spotlight -
  • Expert Perspectives on Personal Protection Guidelines and Standardization Practices
  • Bug of the Month
Advanced Technology
Bug of the Month
COVID-19
Environmental Services
HAIs
Hand Hygiene
Long-Term Care
Operating Room
Personal Protective EquipmentPersonal Protective Equipment
Prevention
Sterile Processing
Surface Disinfection
Vascular Access
    • News
    • Conference
Advertisement

Zika Infects Neural Cells Related to Skull Formation, Affecting Their Function

Oct 3, 2016
Article

Cranial neural crest cells-which give rise to the bones and cartilage of the skull-are vulnerable to Zika virus, report Stanford University School of Medicine researchers September 29 in Cell Host & Microbe. The discovery, made by infecting in vitro cultures of human cells, offers a potential mechanism for how children born with the virus can have smaller-than-average skulls and disproportionate facial features.

This image shows neural stem cells after being treated with LIF signaling molecules, 20 times magnification. Courtesy of Rachel Greenberg

Cranial neural crest cells-which give rise to the bones and cartilage of the skull-are vulnerable to Zika virus, report Stanford University School of Medicine researchers September 29 in Cell Host & Microbe. The discovery, made by infecting in vitro cultures of human cells, offers a potential mechanism for how children born with the virus can have smaller-than-average skulls and disproportionate facial features.

The researchers also found that Zika has slightly different effects on cranial neural crest cells compared to neural progenitor cells, which have received much attention due to their connection with microcephaly. While the virus rapidly kills neural progenitor cells, infection of cranial neural crest cells does not lead to high rates of cell death. Instead, Zika causes them to secrete signaling molecules that promote the formation of new neural cells. In cell culture, elevated levels of these molecules were enough to induce premature differentiation, migration, and death of human neural progenitors.

“In addition to direct effects of Zika virus on neural progenitors and their derivatives, this virus could affect brain development indirectly, through a signaling cross-talk between embryonic cell types,” says co-senior author Joanna Wysocka, a chemical and systems biologist at the Stanford University School of Medicine. “Neural crest cells are one example, but such mechanisms may also be relevant to other tissues that come in contact with the developing brain during head formation and could be infected by Zika virus.”

Wysocka and co-senior author Catherine Blish, a Stanford clinician-scientist, were interested in studying cranial neural crest cells because during embryogenesis they form the majority of bone and cartilage of the head and communicate with the developing brain. They hypothesized that infection of cranial neural crest cells by Zika could cause the disruption in this communication.

“Our in vitro studies raise an intriguing possibility that the Zika virus can infect human cranial neural crest cells in the developing embryo, which in turn could influence brain development through altered paracrine signaling-and also potentially directly affect development of craniofacial structures,” Wysocka says. “As neural crest cell formation occurs during a specific window of embryogenesis (namely, the first trimester, which intriguingly has been correlated with poor birth outcomes in Zika-infected mothers), we do not anticipate similar effects in adults.”

While an interesting line of future study, the authors emphasize that they have no direct proof that Zika virus infects cranial neural crest cells in animals or humans, nor evidence that such infection would be sufficient to result in microcephaly.

This work was supported by the Stanford Child Health Research Institute and Stanford University School of Medicine, the National Institutes of Health, the March of Dimes Birth Defects Foundation, the Howard Hughes Medical Institute, the National Institute of Dental and Craniofacial Research, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and a Stanford Systems Biology Seed Grant.

Source: Stanford University School of Medicine

Related Videos
Medical investigators going over data. (AdobeStock 589197902 by Wasan)
CDC logo is seen on a laptop. (Adobe Stock 428450603 by monticellllo)
Association for the Health Care Environment (Logo used with permission)
Ambassador Deborah Birx, , speaks with Infection Control Today about masks in schools and the newest variant.
mRNA technology  (Adobe Stock 485886181 by kaptn)
Ambassador Deborah Birx, MD
Woman lying in hospital bed (Adobe Stock, unknown)
Photo of a model operating room. (Photo courtesy of Indigo-Clean and Kenall Manufacturing)
GIANTmicrobes at the 2023 APIC Annual Conference and Exhibition.  (Photo by the author)
Related Content

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

September 22nd 2023

NIH Announces HIV Vaccine Clinical Trial Begins

September 20th 2023

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy  

September 18th 2023

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

September 18th 2023

Protecting HCWs: Plague Doctor's Masks to the Personal Protective Equipment of Tomorrow

September 15th 2023

AHE Exchange Conference & Solution Center 2023 Review

September 14th 2023

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

September 22nd 2023

NIH Announces HIV Vaccine Clinical Trial Begins

September 20th 2023

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy  

September 18th 2023

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

September 18th 2023

Protecting HCWs: Plague Doctor's Masks to the Personal Protective Equipment of Tomorrow

September 15th 2023

AHE Exchange Conference & Solution Center 2023 Review

September 14th 2023

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

September 22nd 2023

NIH Announces HIV Vaccine Clinical Trial Begins

September 20th 2023

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy  

September 18th 2023

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

September 18th 2023

Protecting HCWs: Plague Doctor's Masks to the Personal Protective Equipment of Tomorrow

September 15th 2023

AHE Exchange Conference & Solution Center 2023 Review

September 14th 2023
Related Content
Advertisement

weekly rounds with infection control today

Weekly Rounds: Data-Driven Action Against COVID-19, Emerging Pathogens, HIV Vaccine Trials Begin, and More

September 22nd 2023
Article

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending September 24, 2023.


NIH Announces HIV Vaccine Clinical Trial Begins

NIH Announces HIV Vaccine Clinical Trial Begins

September 20th 2023
Article

A new preventative vaccine has been developed incorporating technology funded by the NIH since 2004. The trials will be conducted in the United States and South Africa.


Vial of COVID-19 vaccine, bottle for injection with syringe.  (Adobe Stock 331786954 by myskin)

Organized Disinformation Fanning the COVID-19 Flames of Vaccine Hesitancy  

September 18th 2023
Article

Randomized controlled trials show masks are effective. With COVID-19, even one mistake in protective gear usage could lead to infection and obscure results.


In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses COVID-19 vaccines and boosters, Legionella infections from transplants, and hospital leadership.

Hot Topics in IPC: COVID-19 Updated Booster, Legionella Infections, and Hospital Leadership

September 18th 2023
Article

In this Hot Topics in IPC, Saskia v. Popescu, PhD, MPH, MA, CIC, FAPIC, discusses COVID-19 vaccines and boosters, Legionella infections from transplants, and hospital leadership.


Plague doctor, a physician who treated bubonic plague.  (Adobe Stock FILE #: 559266031 by Worldillustrator)

Protecting HCWs: Plague Doctor's Masks to the Personal Protective Equipment of Tomorrow

September 15th 2023
Article

Plague doctors' historical attire was an early form of PPE. While modern PPE has improved, the quest for better, more comfortable protection continues as we aim for a future where health care workers can provide care confidently.


AHE: Association for the Health Care Environment  (Photo used with permission by AHE)

AHE Exchange Conference & Solution Center 2023 Review

September 14th 2023
Article

Health care environmental professionals met in Dallas, Texas, from July 31 to August 2, 2023, at the AHE Exchange Conference & Solution Center. Infection Control Today® asked Rock Jensen, AHE advisory board chair and administrative director of support services for Yuma Regional Medical Center in Arizona, about AHE’s areas of emphasis for leadership in environmental services (EVS).

Advertise
About Us
Editorial Board
Contact Us
Job Board
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News